鼻内芬太尼联合吸入一氧化二氮用于骨折复位:FAN观察性研究
这项双中心前瞻性观察性队列研究纳入90例4–18岁接受鼻内芬太尼联合一氧化二氮程序性镇静镇痛进行轻度/中度移位骨折或脱位复位的患儿。术中以面部疼痛量表修订版(FPS-R)评估疼痛,术中中位评分2分,与术前2分无差异;FLACC评分术中中位4分,显著高于术前的0分(Δ 2,95%CI 0, 2)。中位UMSS为1分(95%CI 1, 2),无严重不良事件,呕吐发生率12%(11/84)。家长85/88(97%)、患儿74/83(89%)、医生82/85(96%)愿意再次使用相同镇静方案。作者认为该方案有效、安全且满意度高。
要点
- 双中心前瞻性观察性队列纳入90例4–18岁患儿,鼻内芬太尼联合一氧化二氮用于轻度/中度移位骨折或脱位复位。
- 术中FPS-R中位评分2分,与术前2分无差异;FLACC评分术中中位4分,显著高于术前0分(Δ 2,95%CI 0, 2)。
- 中位UMSS为1分(95%CI 1, 2),无严重不良事件,呕吐发生率12%(11/84)。
- 家长97%(85/88)、患儿89%(74/83)、医生96%(82/85)表示愿意再次使用相同镇静方案。
适用人群与场景
- 4–18岁患儿,因轻度/中度移位骨折或脱位需在急诊行复位,接受鼻内芬太尼联合一氧化二氮程序性镇静镇痛。
处置流程与药物剂量
- 鼻内芬太尼联合吸入一氧化二氮用于轻度/中度移位骨折或脱位复位时的程序性镇静镇痛;原文未给出具体剂量、给药频次或目标值。
研究设计与关键结果
- 双中心前瞻性观察性队列研究,纳入90例4–18岁患儿,干预为鼻内芬太尼联合一氧化二氮程序性镇静镇痛下复位轻度/中度移位骨折或脱位。
- 术中FPS-R中位评分2分 vs 术前2分,无差异;FLACC评分术中中位4分 vs 术前0分,显著升高(Δ 2,95%CI 0, 2)。
- 中位UMSS为1分(95%CI 1, 2);无严重不良事件;呕吐发生率12%(11/84)。
- 满意度:家长85/88(97%)、患儿74/83(89%)、医生82/85(96%)愿意再次使用相同镇静方案。
证据类型、等级与局限
- 证据类型:双中心前瞻性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,鼻内芬太尼联合一氧化二氮程序性镇静镇痛对于轻度/中度移位骨折或脱位复位有效、安全且满意度高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Procedural sedation and analgesia (PSA) are frequently used for fracture reduction in pediatric emergency departments (ED). Combining intranasal (IN) fentanyl with inhalation of nitrous oxide (N2O) allow for short recovery time and obviates painful and time-consuming IV access insertions.
METHODS: We performed a bicentric, prospective, observational cohort study. Patients aged 4-18years were included if they received combined PSA with IN fentanyl and N2O for the reduction of mildly/moderately displaced fracture or of dislocation. Facial Pain Scale Revised (FPS-R) and Face, Leg, Activity, Cry, Consolability (FLACC) scores were used to evaluate pain and anxiety before, during and after procedure. University of Michigan Sedation Score (UMSS), adverse events, detailed side effects and satisfaction of patients, parents and medical staff were recorded at discharge. A follow up telephone call was made after 24-72h.
RESULTS: 90 patients were included. There was no difference in FPS-R during the procedure (median score 2 versus 2), but the FLACC score was significantly higher as compared to before (median score 4 versus 0, Δ 2, 95% CI 0, 2). Median UMSS was 1 (95% CI 1, 2). We recorded no serious adverse events. Rate of vomiting was 12% (11/84). Satisfaction was high among participants responding to this question 85/88 (97%) of parents, 74/83 (89%) of patients and 82/85 (96%) of physicians would want the same sedation again.
CONCLUSION: PSA with IN fentanyl and N2O is effective and safe for the reduction of mildly/moderately displaced fracture or dislocation, and has a high satisfaction rate.
参考来源
- Hoeffe J, Doyon Trottier E, Bailey B, et al. Intranasal fentanyl and inhaled nitrous oxide for fracture reduction: The FAN observational study. Am J Emerg Med. 2017. PMID: 28190665. doi:10.1016/j.ajem.2017.01.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。